Page last updated: 2024-12-06

propiram

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

propiram: RN given refers to parent cpd; synonym Bay 4503 refers to fumarate[1:1]; practically always used as fumarate in medicine; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID26216
CHEMBL ID2110985
CHEBI ID135140
SCHEMBL ID26193
MeSH IDM0042579

Synonyms (41)

Synonym
52373-67-8
wt6247u6px ,
unii-wt6247u6px
propiramum
propiramo
propiram
15686-91-6
n-(1-methyl-2-piperidin-1-ylethyl)-n-pyridin-2-ylpropanamide
propanamide, n-(1-methyl-2-(1-piperidinyl)ethyl)-n-2-pyridinyl-
dea no. 9649
propionamide, n-(1-methyl-2-piperidinoethyl)-n-2-pyridyl-
einecs 239-775-7
propiramo [inn-spanish]
brn 0485057
n-(1-methyl-2-(1-piperidinyl)ethyl)-n-2-pyridinylpropanamide
propiramum [inn-latin]
isopropiram
propiram [inn:ban]
pregnane-11,20-dione, 3,21-dihydroxy-, (3-alpha,5-alpha)-
(rs)-cis-n-(2-piperidinopropyl)-n-2-pyridylpropionamide
propionamide, n-(1-methyl-2-(1-piperidinyl)ethyl)-n-2-pyridyl-
propionamide, n-(2-piperidinopropyl)-n-2-pyridyl-, (rs)-(z)-
CHEBI:135140
L004589
n-(1-piperidin-1-ylpropan-2-yl)-n-pyridin-2-ylpropanamide
SCHEMBL26193
n-(1-methyl-2-piperidinoethyl)-n-2-pyridylpropionamide
propiram [who-dd]
bay-4503 free base
ids-np-016(sect.2)
(+/-)-propiram
propiram [mi]
propiram [inn]
propanamide, n-[1-methyl-2-(1-piperidinyl)ethyl]-n-2-pyridinyl-
CHEMBL2110985
ZBAFFZBKCMWUHM-UHFFFAOYSA-N
(.+/-.)-n-(1-methyl-2-piperidinoethyl)-n-2-pyridylpropionamide
n-(1-methyl-2-piperidinoethyl)-n-2-pyridinylpropionamide
propionamide, n-(1-methyl-2-piperidinoethyl)-n-2-pyridyl-, (.+/-.)-
DTXSID1023522
Q7250338

Research Excerpts

Overview

Propiram is an orally administered opioid analgesic. It has partial morphine-like agonist and weak antagonist properties.

ExcerptReferenceRelevance
"Propiram is an orally administered opioid analgesic with partial morphine-like agonist and weak antagonist properties. "( Propiram. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use as an analgesic.
Brogden, RN; Goa, KL, 1993
)
3.17

Bioavailability

ExcerptReferenceRelevance
"Propiram bioavailability was determined in 10 healthy volunteers after a single role administration of 50 mg (base equivalent) of propiram fumarate in tablet or solution dosage from in a randomized crossover design."( Bioavailability of orally administered propiram fumarate in humans.
Chung, M; Korduba, CA; Radwanski, E; Symchowicz, S; Veals, J, 1981
)
1.97

Dosage Studied

ExcerptRelevanceReference
"Propiram bioavailability was determined in 10 healthy volunteers after a single role administration of 50 mg (base equivalent) of propiram fumarate in tablet or solution dosage from in a randomized crossover design."( Bioavailability of orally administered propiram fumarate in humans.
Chung, M; Korduba, CA; Radwanski, E; Symchowicz, S; Veals, J, 1981
)
1.97
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (75.00)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.11 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (50.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (40.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]